NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Geneoscopy

Geneoscopy

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.geneoscopy.com/

Last Round

Series C

Jan 8, 2025

Total Funding Raised

$218.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Geneoscopy is a life sciences company that develops noninvasive diagnostic tests for gastrointestinal health, including colorectal cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B2C

Customer Profile

Usage-Based SaaS

AI Layer

Non-AI

Keywords

colorectal cancer screeningstool-derived eukaryotic RNAseRNAnon-invasive cancer testmulti-target stool RNAmt-sRNAmolecular diagnosticsliquid biopsygastrointestinal healthadvanced adenoma detectiondiagnostic testing servicesProprietary Laboratory AnalysesPLA codebiomarker analyticsat-home cancer test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneoscopy Comps

Public and private peers based on sector, stage, and business model.

Geneoscopy comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Geneoscopy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 8, 2025
DebtNov 16, 2021
Series BNov 16, 2021
Series AOct 2, 2019
SeedApr 1, 2018
Grant
Oct 23, 2017

Key People

Founding team and executive leadership

Andrew Barnell

Co-Founder And Chief Executive Officer

Founding Team

Amit Bhalla

Chief Financial Officer

Executive Team

Geneoscopy Investors

Notable investors and investment history

Geneoscopy investors
InvestorRounds
Innovatus Capital PartnersDebt, Series B
NT InvestmentsSeries C, Debt, Series B, Series A
Petrichor Healthcare Capital ManagementSeries C
Granger ManagementSeries C
Arch GrantsGrant, Seed
NT Investment GroupSeries C
Cultivation CapitalSeries B, Debt, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2026

    Operates a CAP/CLIA-certified diagnostic laboratory.

  • Feb 6, 2026

    Counterclaims filed alleging breach of contract and trade secret misappropriation.

Geneoscopy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneoscopy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneoscopy's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range73
Year Founded2015
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.